ONO PHARMACEUTICAL CO.,LTD. [4528.T]
TOKYO, Jun 18 (Pulse News Wire) – ONO Pharmaceutical CO.,LTD. (4528.T) resolved today to issue restricted stock awards to its directors and executives as part of its performance-based and service-based equity compensation programs.
Under the resolution, the company will distribute ordinary shares worth approximately ¥47.0 million to three non-outsider directors on July 10, 2026 and another set of shares valued at ¥402.7 million to three directors and thirteen executive officers on July 10, 2026. The purpose of these awards is to incentivize long-term value creation and enhance alignment with shareholders' interests. Directors receiving the awards will be subject to holding restrictions until their departure from management positions due to retirement or other valid reasons.
In cases of misconduct or significant violations during the restriction period, the company reserves the right to reclaim the awarded shares without compensation. Additionally, the company plans to enter into agreements detailing the conditions and limitations associated with these restricted stock grants, ensuring compliance with legal requirements and internal regulations. The distribution price per share was determined based on the closing price of Ono Pharmaceutical's ordinary shares on the Tokyo Stock Exchange on June 17, 2026, which was deemed fair and reasonable.
🟡 Confidence: Standard AI-translated content.